Amie Paminiano
About Amie Paminiano
Amie Paminiano is a Senior Hospital and Institutional Cardiovascular Specialty Business Manager at Bristol-Myers Squibb in New York, with over 17 years of experience in cardiovascular specialty business management.
Company
Amie Paminiano is currently employed at Bristol-Myers Squibb as a Senior Hospital and Institutional Cardiovascular Specialty Business Manager. Bristol-Myers Squibb is a global biopharmaceutical company specializing in innovative medicine for serious diseases. Amie has been with the company for over 17 years, showcasing her long-term commitment and expertise in the field.
Title
Amie Paminiano holds the position of Senior Hospital and Institutional Cardiovascular Specialty Business Manager. In this role, she focuses on managing cardiovascular specialty products within hospital and institutional settings. This position requires in-depth knowledge and strategic oversight of the cardiovascular market, patient management, and healthcare collaborations.
Previous Roles
Before joining Bristol-Myers Squibb, Amie Paminiano held several significant roles across different industries. She worked at Forest Laboratories as a Specialty Sales Representative from 2002 to 2006. Prior to that, she was an Account Manager at Yellowbook from 1998 to 2001. Earlier in her career, she served as a Clinical Research Associate in Neurology and Neuropathology at UCSF focusing on prion research studies from 1993 to 1998.
Education and Expertise
Amie Paminiano holds two Bachelor of Science degrees from prestigious institutions—San Francisco State University and the University of California, Berkeley. Her educational background in science has equipped her with a solid foundation for her career in clinical research and business management. With extensive experience in cardiovascular specialty business management, she combines scientific knowledge with strategic sales and account management skills.
Background in Clinical Research
Amie Paminiano has valuable experience in clinical research, particularly in prion research studies within the fields of neurology and neuropathology. Her work at UCSF from 1993 to 1998 involved significant research contributions to the understanding of prion diseases. This background in clinical research adds a depth of scientific understanding to her current role in business management in the healthcare sector.